Full history for every metric is available with a Kvantra account
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 551 | 574 | 593 | 690 | 669 | 673 | 658 | 658 |
| Operating profit | £m | 87 | 87 | ||||||
| Net profit | £m | 35 | 47 | 41 | 33 | 8 | 19 | 285 | 285 |
| EPS reported | £ | 4.25 | 4.25 | ||||||
| Operating cashflow per share | £ | 1.37 | 1.36 | ||||||
| Capex per share | £ | 0.19 | 0.19 | ||||||
| FCF per share | £ | 1.18 | 1.17 | ||||||
| Free cash flow | £m | 78 | 78 | ||||||
| Net debt | £m | 47 | 64 | ||||||
| Book value equity | £m | 767 | 767 | ||||||
| Book value per share | £ | 11.42 | 11.42 | ||||||
| Number of shares | m | 67.11 | 67.13 | ||||||
| DPS (TTM paid) | £ | 0.24 | 0.22 |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 5.05 | - | ||||||
| P/B LTM | x | 1.85 | 1.86 | ||||||
| P/S LTM | x | 2.16 | 2.16 | ||||||
| P/FCF LTM | x | 18.20 | 18.26 | ||||||
| EV/EBITDA LTM | x | 11.57 | 11.60 | ||||||
| EV/Sales LTM | x | 2.25 | 2.26 | ||||||
| Earnings Yield LTM | % | 19.80% | 20.00% | ||||||
| FCF Yield | % | 5.49% | 5.48% | ||||||
| Quality | |||||||||
| ROE | % | 37.21% | 44.90% | ||||||
| ROIC | % | 8.77% | 8.77% | ||||||
| Operating margin | % | 13.27% | 13.27% | ||||||
| Gross margin | % | 100.00% | 96.72% | ||||||
| FCF/Sales | % | 11.85% | 11.85% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +1365.5% | +1365.5% | ||||||
| Sales Growth YoY | % | -2.18% | -2.18% | ||||||
| Net Income Growth YoY | % | +1378.2% | +1378.2% | ||||||
| FCF Growth | % | +60.49% | +60.49% | ||||||
| Operating Profit Growth | % | +105.90% | +105.90% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 1.53% | 1.01% | ||||||
| Dividend Growth | % | +10.60% | - | ||||||
| Payout Ratio | % | 7.61% | 7.61% | ||||||
| FCF/Debt | x | 0.73 | 0.73 | ||||||
| Net Debt/EBITDA | x | 0.50 | 0.50 | ||||||
| EBIT/Net interest | x | 5.36 | 5.36 | ||||||
| Net debt/market cap | % | 3.34% | 4.48% | ||||||
| Net debt/Equity | x | 0.06 | 0.08 | ||||||
| Gross debt/equity | x | 0.14 | 0.14 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Genus plc is a global animal genetics company with operations spanning North America, Latin America, the UK, continental Europe, the Middle East, Russia, Africa, and Asia. The business is divided into three key segments: Genus PIC, Genus ABS, and Genus Research and Development. Under its PIC brand, the company provides breeding stock, including sows, boars, and semen, to develop pigs with specific characteristics optimized for pork production. Similarly, for cattle, its ABS, Genus, and Bovec brands offer bull semen and embryos designed to produce calves with advantageous traits for either milk or beef output. Farmers also benefit from a range of specialized technical services, such as semen sexing and reproductive solutions. Genus plc is also strategically collaborating with Beijing Capital Agribusiness Co. Ltd on the research, development, and regulatory approval of porcine reproductive and respiratory syndrome virus (PRRSV)-resistant pigs in China. The company was established in 1994 and is based in Basingstoke, United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Genus plc is a global animal genetics company with operations spanning North America, Latin America, the UK, continental Europe, the Middle East, Russia, Africa, and Asia. The business is divided into three key segments: Genus PIC, Genus ABS, and Genus Research and Development. Under its PIC brand, the company provides breeding stock, including sows, boars, and semen, to develop pigs with specific characteristics optimized for pork production. Similarly, for cattle, its ABS, Genus, and Bovec brands offer bull semen and embryos designed to produce calves with advantageous traits for either milk or beef output. Farmers also benefit from a range of specialized technical services, such as semen sexing and reproductive solutions. Genus plc is also strategically collaborating with Beijing Capital Agribusiness Co. Ltd on the research, development, and regulatory approval of porcine reproductive and respiratory syndrome virus (PRRSV)-resistant pigs in China. The company was established in 1994 and is based in Basingstoke, United Kingdom.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free